Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Current Assets: 2011-2024

Historic Current Assets for Mimedx Group (MDXG) over the last 14 years, with Dec 2024 value amounting to $191.9 million.

  • Mimedx Group's Current Assets rose 47.61% to $254.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $254.1 million, marking a year-over-year increase of 47.61%. This contributed to the annual value of $191.9 million for FY2024, which is 16.82% up from last year.
  • Latest data reveals that Mimedx Group reported Current Assets of $191.9 million as of FY2024, which was up 16.82% from $164.3 million recorded in FY2023.
  • Mimedx Group's Current Assets' 5-year high stood at $191.9 million during FY2024, with a 5-year trough of $134.2 million in FY2022.
  • Its 3-year average for Current Assets is $163.4 million, with a median of $164.3 million in 2023.
  • Its Current Assets has fluctuated over the past 5 years, first spiked by 30.32% in 2020, then declined by 9.64% in 2022.
  • Over the past 5 years, Mimedx Group's Current Assets (Yearly) stood at $160.6 million in 2020, then decreased by 7.53% to $148.5 million in 2021, then declined by 9.64% to $134.2 million in 2022, then increased by 22.40% to $164.3 million in 2023, then climbed by 16.82% to $191.9 million in 2024.